Levetiracetam monotherapy in children with epilepsy: Experience from a tertiary pediatric neurology center
EPILEPSY & BEHAVIOR, cilt.116, 2021 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 116
- Basım Tarihi: 2021
- Doi Numarası: 10.1016/j.yebeh.2020.107745
- Dergi Adı: EPILEPSY & BEHAVIOR
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, EMBASE, MEDLINE, Psycinfo
- Anahtar Kelimeler: Children, Discontinuation rate, Efficacy, Levetiracetam, Monotheraphy, Safety
- Ankara Üniversitesi Adresli: Evet
Özet
Objectives: Levetiracetam (LEV) is a second-generation antiepileptic drug with high efficacy and tolerability in children and adults with epilepsy. We aimed to retrospectively assess the long-term efficacy, tolerability, and safety of LEV monotherapy in children with epilepsy.